CORDIS Project
Funding breakdown and partner intelligence are Premium
Sign in and upgrade to Premium for EU contribution totals, consortium analytics, OpenAlex research context, and AI summaries. · 0 consortium intelligence fields visible of 1
Start free • Cancel anytime • 14-day refund guarantee
PIcelles aims to develop a novel theranostic nanoformulation for cancer treatment that enhances drug delivery to tumors. This platform integrates imaging capabilities, active targeting, and efficient drug loading to improve patient outcomes in anticancer therapies.
PIcelles will assess the commercial viability of a novel theranostic nanoformulation for anticancer therapy.
Current nanomedicine platforms are not able to boost response rates and survival times due to two main reasons: (1) the high variability in the accumulation of nanomedicines in tumors and metastases; and (2) the poor tissue penetration of nanomedicines in tumors and metastases.
Based on results of the ERC project NeoNaNo, we are developing an imageable and penetration-promoting PIcelles p…
Partner organizations (coordinator is shown above), with normalized type and CORDIS activity type. Guests see up to 4 partners.
Similar projects, consortium collaboration history, frequent partners, and OpenAlex research context.
Guests see up to 5 EuroSciVoc fields.
Guests see up to 5 topics.
